Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
- Status
- COMPLETED
- Phase
- PHASE3
Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE2
Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2